- About Us
- Clinical Trials
Available Clinical Trials
- Resources
- Contact Us
A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients with Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Tria
(See required screening study ECOG-ACRIN EAY191)